Home » Topics » Gastrointestinal, BioWorld Science

Gastrointestinal, BioWorld Science
RSS

Preclinical data support clinical trials of repifermin in ulcerative colitis

Oct. 10, 2000

NitroMed's newest NO- and/or NO2-containing proton pump inhibitors

Oct. 9, 2000

Ribozyme repurchases rights to Heptazyme; phase II trial to begin

Oct. 9, 2000

BioChem Pharma reveals novel compounds for hepatitis C virus

Oct. 6, 2000

Final analysis of ISIS-2302 sparks reinitiation of development

Oct. 5, 2000

Ribozyme presents HBV data, announces formal HBV development program

Oct. 4, 2000

Anti-H. pylori agents prepared and tested at Welfide

Oct. 3, 2000

Efficacy in experimental IBD demonstrated for immunosteroid recently acquired by Hollis-Eden

Oct. 2, 2000

FDA approves Visicol

Sep. 29, 2000

Novel drug target identified for hepatitis B

Sep. 27, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
GSK’s newly acquired Jideytro wins FDA nod in NSCLC
BioWorld
About a week after closing its $10.6 billion acquisition of Nuvalent Inc., GSK plc has reaped the first reward, announcing U.S. FDA approval of zidesamtinib in...